chemXplore tracks 22 projects in Ireland, of which 3 are active.
2 expansion and 1 new construction.
Owners and developers: Dexcom (1), Merck (1), Merck KGaA (1), Novo Nordisk (1)
Investors: Merck KGaA (1)
Contractors are recorded on 1 of these 3 projects For subscribers
Targeting: Glucagon-like peptide-1 (1)
€1bn Europe-wide auction for industrial process-heat decarbonisation; bidding opens early Dec 2026. Supports electrification, renewable heat and SMRs with a fixed premium per tCO2.
CHMP limits ipidacrine to specific neuropathies, Alzheimer’s, intestinal atony and certain stroke/TBI recovery uses; removes several neuritis and demyelinating indications; cautions >80 mg/day.
SAF reached 1.1 Mt (2.8% share), a near sixfold rise from 2024; supplied at 121 airports, 84% produced in the EU, and 18 Member States host production projects.
Study finds Europe needs a step-change in exploration spending and permitting reform to convert geological potential into domestic critical raw materials supply.
€25m anchor aims to mobilise €100m for Seed/Series A agrifood tech; 30% earmarked for Ireland. Article 9 SFDR fund with 90% climate/environment target.
John Smith will lead EMEA architectural coatings from July 1, 2026; Steve Pocock retires June 30, 2026.
CRCF Days launched rollout: certification schemes may seek CRCF recognition; Buyers’ Club to aggregate demand; removals and carbon‑farming methodologies near adoption; financing and de‑risking needed
Telesur–EllaLink deal to build Caribbean Gateway cable linking the Caribbean, Europe, US and Brazil, boosting capacity and redundancy and EU digital resilience; boosts ZILS appeal for data infra
€200m backing to scale biomethane in Europe via greenfield anaerobic‑digestion plants converting agricultural waste; fund targets €1.5bn and aims to strengthen energy security.
Creates TTEP: 14 GW flexible gas/biomass + BESS across Italy, UK, Ireland, Netherlands, France; ~30 TWh output in 2025; tolling contracts; 5 GW development pipeline.
active / all projects
